Stockreport

Kali Therapeutics signs deal with Sanofi to develop autoimmune treatment [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF Here are ?the details: * Under the deal, Sanofi will obtain global rights to KT501,a tri-specific antibody utilizing Kali Therapeutics' proprietarydiscovery and resea [Read more]